-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Astrana Health, Raises Price Target to $53

Benzinga·08/07/2026 10:41:02
Listen to the news
Barclays analyst Andrew Mok maintains Astrana Health (NASDAQ:ASTH) with a Overweight and raises the price target from $50 to $53.